Company intelligence / Profile preview

Northview Ventures

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Northview LifeSciences operates as a strategic investment and consulting platform that creates, finances, and advances early-stage life science companies across therapeutics, medical devices, diagnostics, digital health, human performance products, and supplements, with specific focus areas such as monoclonal antibody therapeutics and targeted alpha radiation therapies for oncology, specialty ophthalmology drugs, and gut health products, but it does not itself appear to sponsor late-stage clinical programs under its own name.[1][2][3][6][7]

Therapeutic areas: OncologyOphthalmologyOtherGastroenterology
Modalities: Monoclonal antibodyTargeted alpha radiation therapySmall moleculeMedical deviceDiagnosticNanoparticle
Industry: Investors

Beyond the preview

Go deeper on Northview Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northview Ventures.

Explore the full profile